Physician profile
Ryan Gibb
NPI 1326366832
$12,259.90
in general payments reported to CMS, 2019-2025
56 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,030 · 2020: $924 · 2021: $3,107 · 2022: $833 · 2023: $1,663 · 2024: $2,168 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,365.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,200.77 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Na |
| Spinal Simplicity, LLC | $1,611.58 | 2021-2024 | Ha Minuteman G3-R |
| Abbott Laboratories | $1,357.14 | 2019-2025 | Proclaim, Prodigy |
| Medtronic, INC. | $746.42 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Saluda Medical Americas, INC. | $678.31 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic USA, INC. | $635.09 | 2019-2020 | |
| Nalu Medical, INC. | $404.06 | 2021-2024 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $373.60 | 2019-2025 | Relistor |
| Nevro Corp. | $286.26 | 2021-2023 | Senza |
| Abbvie INC. | $282.82 | 2022-2025 | |
| Relievant Medsystems, INC. | $277.84 | 2019-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $268.04 | 2019-2025 | Xtampza, Belbuca |
| Tersera Therapeutics LLC | $181.88 | 2019-2023 | Prialt |
| Daiichi Sankyo INC. | $169.09 | 2019 | |
| Spr Therapeutics, INC | $161.06 | 2024-2025 | Sprint Pns System |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Gibb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.